The integration of EndoZip into practice at the Institute of Image-Guided Surgery in Strasbourg follows successful commercial launches in Italy and Spain. By automating the suturing process, the device aims to resolve the technical barriers that have historically limited ESG to a small group of highly specialized endoscopists. Prof. Perretta, a leader in foregut and bariatric surgery, noted that simplifying the procedural workflow is essential for increasing patient access to minimally invasive obesity treatments.
Nitinotes CEO Lloyd Diamond emphasized that the move into the French market validates the company’s strategy of reaching beyond traditional endoscopy circles. As surgeons gain access to automated platforms, the company anticipates a more standardized approach to tissue approximation. While the system holds CE Mark approval for use across the European Union, it remains restricted to investigational use for clinical teams in the United States.

Comments (0)
No comments yet. Be the first!